Advertisement
Advertisement
NEOG
Neogen Corp
8.94
USDSponsored
+0.58
+6.91%
Mar 23, 12:03 UTC -4
Open
NEOG Earnings Reports
Positive Surprise Ratio
NEOG beat 12 of 40 last estimates.
30%
Next Report
Date of Next Report
Apr 01, 2026
Estimate for Q3 26 (Revenue/ EPS)
$208.58M
/$0.05
Implied change from Q2 26 (Revenue/ EPS)
-7.17%
/-50.00%
Implied change from Q3 25 (Revenue/ EPS)
-5.61%
/-50.00%
Neogen Corp earnings per share and revenue
On Jan 08, 2026, NEOG reported earnings of 0.10 USD per share (EPS) for Q2 26, beating the estimate of 0.05 USD, resulting in a 78.25% surprise. Revenue reached 224.69 million, compared to an expected 212.00 million, with a 5.98% difference. The market reacted with a +31.57% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 208.58 million USD, implying an decrease of -50.00% EPS, and decrease of -7.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Neogen Corp's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Neogen Corp reported EPS of $0.10, beating estimates by 78.25%, and revenue of $224.69M, 5.98% above expectations.
How did the market react to Neogen Corp's Q2 2026 earnings?
The stock price moved up 31.57%, changed from $7.38 before the earnings release to $9.71 the day after.
When is Neogen Corp expected to report next?
The next earning report is scheduled for Apr 01, 2026.
What are the forecasts for Neogen Corp's next earnings report?
Based on 7
analysts, Neogen Corp is expected to report EPS of $0.05 and revenue of $208.58M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement